@article{6153e1c81942481b96362f0f52d8f38b,
title = "Adapted whole-body surveillance for von Hippel–Lindau-associated tumors in 3p deletion syndrome with VHL deletion: A case report",
author = "Kazumi Morisawa and Takeshi Sato and Motoko Shimoyamada and Ryuichi Mizuno and Hirofumi Ohashi and Hiromi Watanabe-Hisazumi and Kaoru Takeshima and Atsuhiro Kojima and Seiji Sato and Tomonobu Hasegawa and Takao Takahashi",
note = "Funding Information: Tomonobu Hasegawa has the following financial relationships to disclose: Research funding from Novo Nordisk Pharma Ltd. and JCR Pharmaceuticals Co., Ltd. The other authors have no conflict of interest. Funding Information: informationNovo Nordisk Pharma Ltd.; JCR Pharmaceuticals Co., Ltd.We thank the patient's family for their participation in this study.",
year = "2022",
month = nov,
doi = "10.1002/pbc.29732",
language = "English",
volume = "69",
journal = "Medical and Pediatric Oncology",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "11",
}